<DOC>
	<DOCNO>NCT01424462</DOCNO>
	<brief_summary>This study investigate 3 new type drug formulation absorb body . This study term 'open-label ' , mean volunteer aware treatment receiving . The study involve volunteer receive 3 different formulation , single dose , placebo ( dummy-drug ; active ingredient ) study . Volunteers also receive single dose formulation use previous trial ( reference formulation ) , proper comparison new formulation make . One new formulation also administer along food , assess drug performs absorb differently .</brief_summary>
	<brief_title>Healthy Volunteer Pilot Study Using 3 Types Modified Release Formulations Firategrast Investigate How Quickly Absorption From Digestive System Takes Place .</brief_title>
	<detailed_description>The present study investigate tolerability pharmacokinetics single oral dos firategrast administer exist immediate release tablet formulation three modify release tablet formulation design release drug differ relase rate . The range release rate expect give preliminary information performance matrix modify release formulation use future efficacy study . Subjects receive formulation fast state randomise 4-part single dose crossover fashion . Based review pharmacokinetic data least first two study session , subject may also receive fifth dose firategrast , administer high fat meal . The formulation administer food chosen base upon pharmacokinetic data previous dose session . Doses administer different respect gender ; dos expect result similar exposure across gender .</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Male female , age 18 65 yr inclusive Healthy , determine study physician Capable give informed consent Positive drug abuse result Positive HIV Hepatitis B and/or C viruses History alcohol consumption excess average recommend weekly intake ( 21 unit male , 14 unit female ) Participation clinical trial within 90 day schedule first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>firategrast</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>modify release</keyword>
</DOC>